Knowing when to refer young patients to ocular genetics programmes

Ophthalmology Times EuropeOphthalmology Times Europe October 2022
Volume 18
Issue 08

Clinicians need to investigate patients’ history, family history, visual behaviours and general health in order to promptly and accurately refer paediatric cases to ocular genetics clinics.

Reviewed by Dr Ajoy Vincent.

Knowing when to refer young patients to ocular genetics programmes

Genetic testing is key to confirm an ocular genetics disorder and direct patients in the paediatric setting to appropriate resources, according to Dr Ajoy Vincent, medical director of the visual electrophysiology unit at The Hospital for Sick Children, Toronto and an associate professor of ophthalmology at the University of Toronto in Canada.

During his presentation at the 32nd Annual Jack Crawford Day, an annual paediatric ophthalmology update held virtually in April 2022 by the University of Toronto and The Hospital for Sick Children, Dr Vincent discussed when the decision should be made to refer paediatric cases to an ocular genetics clinic. He underlined that a prompt diagnosis will result in appropriate management and disease prognostication, and that it is important that the clinician has a high index of suspicion when seeing paediatric patients who have various visual challenges.

Triage and investigation

Dr Vincent outlined the general workflow in ocular genetics. This starts with initial triage of a suspected genetic disorder, with cases directed to a specific ocular genetics clinic or a subspecialty clinic such as cornea, glaucoma, anterior segment, neuro-ophthalmology or oculoplastics.

All cases typically undergo multimodal ophthalmic imaging and/or electrodiagnostic testing, he added. After this, a provisional diagnosis is reached and genetic testing is offered to the family, as well as counselling and other support services.

Dr Vincent noted that there are numerous symptoms or clinical scenarios in children that may indicate an underlying genetic condition. For example, when a baby exhibits poor visual behaviour with or without wandering eye movement, common causes can include bilateral cataracts, cortical visual impairment, developmental eye defects or inherited retinal dystrophy.

Hence, clinicians need to note any details of change in visual behaviour, family history of retinal dystrophy and the child’s perinatal history to differentiate between the various causes. “All pertinent information should be included in the referral,” Dr Vincent stated.

A prompt diagnosis will result in appropriate management and disease prognostication.

Dr Vincent went on to emphasise, “Some cases require urgent care whereas others may involve a slower referral pattern.” One example of a symptom that may suggest a need for immediate care is nystagmus that presents in a baby. He explained that this condition can be attributed to several factors such as bilateral media opacity, bilateral retinal disease, bilateral optic nerve abnormality and albinism; he noted that retinal dystrophies, metabolic disorders and vestibular disorders can also be responsible for nystagmus.

“One thing that should be evaluated is the direction of the nystagmus, whether it is horizontal, vertical or torsional,” Dr Vincent said. “It should also be evaluated to determine if it is bilateral or unilateral, symmetrical or asymmetrical, conjugate or dysconjugate, and the age of onset.”

If a child has vertical nystagmus or torsional nystagmus that is asymmetrical, dysconjugate in nature, and appears in the first 6 months of life, the nystagmus can be suggestive of a tumour, Dr Vincent said. “This can be indicative of an optic pathway glioma. It is important to state this in the referral so that the patient can be immediately seen by the neuro-ophthalmology team at the hospital. Relevant history can help us to better help these children.”

Another presenting symptom that can include a genetic component is night blindness or nyctalopia. “Commonly, this can be an indication for inherited retinal dystrophy,” Dr Vincent said, citing retinitis pigmentosa as an example.

He noted that another of the reasons for night blindness may be vitamin A deficiency. “These days, sometimes we see children who have vitamin A deficiency because they have picky eating habits,” he said. “Some of these patients have autistic spectrum disorder, which can influence eating behaviours.”

In these cases, Dr Vincent noted it can be important for the ophthalmologist to ask about a patient’s history, family history and any symptoms of constriction of visual field. “Ask if the child bumps into objects, or ask about any general health-related questions regarding hearing, kidney health, heart health or digital anomalies, as this may help to diagnose complex (syndromic) disorders,” he said. “Include any relevant information in the referral.”

If a child’s visual acuity cannot be fully corrected for their age with glasses, if the fundus exam is normal and if the child does not have amblyopia, then a retinal dystrophy is a likely diagnosis and requires a referral, Dr Vincent said. If the fundus exam is abnormal, it could either be because of macular dystrophy or be due to an optic neuropathy of various aetiologies.

Progressive distance vision loss over a short period of time is another clinical scenario that requires a referral, Dr Vincent noted. “You have to determine if it is sudden onset over a few days or over a period of a few months,” he said. “If it is a few days, it is likely an optic neuropathy or neuritis or acquired maculopathy. If it has been over a period of a few months, it could be the beginning of macular dystrophy or Batten disease, with the latter being a neurodegenerative condition.”

Genetic testing can be useful because it can provide an accurate diagnosis and prognosis, Dr Vincent emphasised, pointing to retinitis pigmentosa as a case in point. “There are over 100 genes that can cause retinitis pigmentosa,” he said.

He pointed out that not all cases of retinitis pigmentosa have the same disease progression or disease pathway. “It can be specific for various genes, so it is very important that we do genetic testing and confirm the diagnosis. In this way, we can [give patients an] accurate or a more reasonably accurate prognosis.”

Ajoy Vincent, MBBS, MS, FICO
Dr Vincent has no financial disclosures related to this content.
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.